Welcome to our dedicated page for CoreWeave SEC filings (Ticker: CRWV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CoreWeave, Inc. filings document the regulatory record for an AI cloud infrastructure company listed on Nasdaq with Class A common stock. The company’s 8-K reports cover operating results, customer cloud-capacity agreements, private placements of equity securities, senior notes, credit facilities, and related guarantees or collateral arrangements.
Proxy materials disclose annual meeting matters, stockholder voting items, board governance, executive compensation, and equity-award information. Capital-structure filings describe senior unsecured notes due 2031, subsidiary guarantees, private placement registration rights, and debt facilities used to finance GPU servers and related infrastructure for customer contracts.
CRWV reported multiple Section 144 resale notices and scheduled 10b5-1 sales of common stock. The filing lists individual sales by trusts and related parties, including transactions dated 04/01/2026 and earlier dates in 2026, with per‑trade share counts and gross proceeds shown.
Morgan Stanley Smith Barney LLC reported Section 144 sale notices for CRWV related positions, listing multiple 10b5-1 planned sales and individual dispositions. The filing lists a Founders Shares lot of 467,939 shares dated 12/27/2023 and individual sale entries such as 493,600 shares by West Clay Capital LLC on 04/01/2026.
CRWV reported Form 144 sales of common stock under pre-arranged 10b5-1 plans. The excerpt lists multiple sale dates and quantities, including 281,250 shares on several dates in 2026 and a 65,005-share sale on 03/31/2026. Transactions are described as 10b5-1 sales by WEST CLAY CAPITAL LLC and sales by Brian Venturo.
CRWV filings report multiple Rule 144/10b5-1 dispositions of Common stock by affiliated holders and an individual. The notice lists scheduled 10b5-1 sale tranches of 281,250 shares on several dates and an additional 65,005-share sale on 03/31/2026. The filings identify Founders Shares and show gross proceeds for each tranche.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting 107,693 shares of Common stock for sale. The filing lists multiple 10b5-1 sales by named holders, with individual sale dates and proceeds shown through 04/01/2026.
Morgan Stanley Smith Barney LLC submitted a Form 144 disclosing multiple planned or completed sales of Common shares tied to 10b5-1 plans and other resale activity. The excerpt lists individual transactions by Michael Intrator, OMNADORA CAPITAL LLC, and Fidelity Charitable with dates, share counts, and dollar amounts.
Morgan Stanley Smith Barney LLC submitted a Form 144 notice reporting planned sales of Common stock by various holders, including multiple 10b5-1 programmed disposals executed March–January 2026. Representative transactions include 77,939 shares on 03/31/2026 and 86,710 shares on 03/05/2026.
CRWV notice of proposed sale: 200,000 shares of Common Stock registered for sale, showing an aggregate dollar amount of $15,494,000.00. The filing lists shares outstanding of 419,028,081 as of 04/01/2026. Multiple prior 10b5-1 sales by related parties are itemized with transaction dates and per-sale share counts and proceeds.
CRWV insiders reported multiple sales of Common Stock under Rule 10b5-1 plans, as shown on Form 144. The filings list several transactions by Brian Venturo and by West Clay Capital LLC across January–March 2026, with per-trade share counts and gross proceeds disclosed.
CRWV reporting proposed sales of Common stock under Rule 144 and 10b5-1 plans. The filing lists multiple dispositions by Brian Venturo and West Clay Capital LLC, including recent 10b5-1 sales of 281,250 shares on several dates and a 65,005-share sale on 03/31/2026. The transactions are presented as sales executed under pre-arranged plans.